Aleix Prat: The new strategies for each of the subtypes of breast cancer
Aleix Prat shared on LinkedIn:
“A new episode of the Podcast Con Cáncer y Con Metas is now available!!
Dr. Elia Seguí, MD Hospital Clinic of Barcelona Dana-Farber Cancer Institute tells us about the most interesting presentations in SABCS24 and her reflections on the new strategies for each of the subtypes of breast cancer. In addition, she has told us first-hand what it is like to carry out research at the Dana-Farber Cancer Center, a well-known institution in the world of oncology where Dr. Seguí is doing a fellowship.”
Aleix Prat is the Director of the Cancer Institute at the Hospital Clinic of Barcelona, Head of the Translational Genomics Group at IDIBAPS, and a Professor at the University of Barcelona.
He is also a Co-Founder of REVEAL GENOMICS, S.L. His work focuses on breast cancer genomics and the development of omics-based assays for clinical application. His expertise lies in breast cancer and gene expression profiling.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023